COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (AMEX:CLN) announced today that it has acquired exclusive worldwide rights for use of pegylation technology with its heat activated liposome technology. The pegylation technology was developed by scientists at PolyMASC in the UK and is covered by granted patents and subsequent patent applications now owned by Valentis Inc. of Burlingame, CA. Celsion’s heat activated liposome technology was developed by scientists at Duke University and is covered by granted patents and subsequent patent applications and was exclusively licensed by Celsion in 1999.
